Natixis

SEC CIK: 0001274981
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

ABT holding history

Abbott Laboratories in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overview All 13F holders of ABT Full Q2 2026 holdings

Shares (Q2 2026): 185,746
Value: $16.9M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of ABT by Natixis, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	185,746	$16.9M	0.1%	−593,157−76.2%	Reduced	Holders
Q1 2026	778,903	$80.0M	0.3%	+491,506+171.0%	Added	Holders
Q4 2025	287,397	$36.0M	0.1%	−382,658−57.1%	Reduced	Holders
Q3 2025	670,055	$89.7M	0.5%	+328,928+96.4%	Added	Holders
Q2 2025	341,127	$46.4M	0.2%	−63,144−15.6%	Reduced	Holders
Q1 2025	404,271	$53.5M	0.3%	+104,996+35.1%	Added	Holders
Q4 2024	299,275	$33.9M	0.2%	−110,264−26.9%	Reduced	Holders
Q3 2024	409,539	$46.7M	0.3%	−112,506−21.6%	Reduced	Holders
Q2 2024	522,045	$54.2M	0.3%	+309,879+146.1%	Added	Holders
Q1 2024	212,166	$24.1M	0.1%	−345,085−61.9%	Reduced	Holders
Q4 2023	557,251	$61.3M	0.5%	−57,381−9.3%	Reduced	Holders
Q3 2023	614,632	$59.5M	0.5%	−115,016−15.8%	Reduced	Holders
Q2 2023	729,648	$79.5M	0.7%	+303,070+71.0%	Added	Holders
Q1 2023	426,578	$43.2M	0.4%	+221,151+107.7%	Added	Holders
Q4 2022	205,427	$22.6M	0.1%	−111,693−35.2%	Reduced	Holders
Q3 2022	317,120	$30.9M	0.1%	+102,676+47.9%	Added	Holders
Q2 2022	214,444	$23.2M	0.1%	−631,967−74.7%	Reduced	Holders
Q1 2022	846,411	$100.2M	0.3%	+771,111+1,024.1%	Added	Holders
Q4 2021	75,300	$10.6M	<0.1%	−591,821−88.7%	Reduced	Holders
Q3 2021	667,121	$78.8M	0.3%	−94,496−12.4%	Reduced	Holders
Q2 2021	761,617	$88.3M	0.4%	+339,574+80.5%	Added	Holders
Q1 2021	422,043	$50.6M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.